Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

Leiping Zeng(Stanford University), Lei S. Qi(Chan Zuckerberg Initiative (United States))

Nature Communications

May 19, 2022

10.1038/s41467-022-30546-7

Cited by 50

Related Papers

A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells

|Cell|2024|108

Virus-derived Synthetic Riboswitches for Real-time Coronaviruses Sensing in Live Cells

|bioRxiv (Cold Spring Harbor Laboratory)|2024|0